Florida S0860 prohibits the sale of compounded weight loss medications without FDA-compliant documentation.
Florida S0860 creates a new section in state law to regulate compounded medications, specifically those used for weight loss. The bill mandates that any person or entity selling such medications must provide documentation to the Department of Business and Professional Regulation. This documentation must certify that the active pharmaceutical ingredient used is identical to that in FDA-approved drugs, is pharmaceutical-grade, and is manufactured in an FDA-registered facility inspected within the last two years. Violations of this provision are subject to fines and license revocation.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.